<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04052165</url>
  </required_header>
  <id_info>
    <org_study_id>Oktariana</org_study_id>
    <nct_id>NCT04052165</nct_id>
  </id_info>
  <brief_title>IOP Reduction and Complications of Polymethyl Methacrylate GDD on Glaucoma Patient</brief_title>
  <official_title>IOP Reduction and Complications of Polymethyl Methacrylate Glaucoma Drainage Device on Glaucoma Patient</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Indonesia University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Fakultas Kedokteran Universitas Indonesia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Dr Cipto Mangunkusumo General Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Institut Pertanian Bogor</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Indonesia University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Glaucoma is a group of diseases that damage the eye's optic nerve, result in progressive
      visual field defect and blindness. The aim of glaucoma management is to reduce IOP, and
      glaucoma implant surgery is the alternative treatment that can be chosen. The effectiveness
      of the implant on the end stage glaucoma patients was evaluated by the reduction of intra
      ocular pressure (IOP) and well formed blebs that were evaluated clinically and by using
      anterior scanning optical coherence tomography (AS-OCT). The safety of the implant was
      determined by the regression of the clinical symptoms and there were no severe complications
      such as implant extrusion. Two patients developed improvement of the visual acuity. This was
      an unpredictable positive result.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study is to measure the efficacy of new GDD that made with polymethyl methacrylate. The
      primary outcome is IOP reduction. The secondary outcome is glaucoma medication post surgery
      and complication that occurred during the follow up. The subjects are refractory glaucoma
      patients that need glaucoma drainage device implantation. The measurement are collected on
      first day, first month, third month, sixth month and twelve month. The IOP will be measured
      using GAT (Goldmann applanation tonometer), but if the subjects are not cooperative, they
      will be measured using i-care. On the follow up, the glaucoma medication needed will be noted
      and also for the complication and the need for other surgery, e.g. AC formation using
      viscoelastic, repair tube/plate exposure, cyclo photocoagulation, etc.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 1, 2015</start_date>
  <completion_date type="Anticipated">August 8, 2020</completion_date>
  <primary_completion_date type="Actual">August 1, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>GDD in glaucoma patient</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>IOP reduction of Polymethylmethacrylate Glaucoma Drainage Device in refractory Glaucoma Patients</measure>
    <time_frame>pre implantation surgery, day 1, 7, 30, 60, 90 post implantation surgery</time_frame>
    <description>Intraocular pressure (IOP)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The glaucoma medication that was used pre and post operative</measure>
    <time_frame>pre implantation surgery, day 1, 7, 30, 60, 90 post implantation surgery</time_frame>
    <description>The glaucoma medication used pre and post op</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The complications that occurred during the follow up</measure>
    <time_frame>during the surgery, day 1, 7, 30, 60, 90 post implantation surgery</time_frame>
    <description>The complications that occurred during the follow up</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Glaucoma Eye</condition>
  <arm_group>
    <arm_group_label>Glaucoma drainage device in glaucoma patient</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>GDD is inserted in glaucoma patients</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Glaucoma Implant</intervention_name>
    <arm_group_label>Glaucoma drainage device in glaucoma patient</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  End stage glaucoma patients whose IOP is failed to be controlled by glaucoma
             medications

          -  Patients that are willing to participate in the study

          -  Patients with &lt;6/60 visual acuity

          -  Patients above 18 years

        Exclusion Criteria:

          -  Patients with combination surgery indication (eg. glaucoma with cataracts)

          -  Eyes with congenital disease of anterior segment dysgenesis

          -  Eyes with uneven surface of the cornea that the measurement IOP with Goldmann
             tonometer could be difficult

          -  Eyes with broad conjungtival cicatrix that are impossible to be implanted
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Virna Dwi Oktariana Asrory, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Indonesia University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Virna Dwi Oktariana Asrory, PhD</last_name>
    <email>virnadwi_dr@yahoo.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Cipto Mangunkusumo Hospital</name>
      <address>
        <city>Jakarta Pusat</city>
        <state>Jakarta</state>
        <zip>10430</zip>
        <country>Indonesia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andi A Victor, PhD</last_name>
      <phone>+62 21 31934878</phone>
      <email>info@rscm.co.id</email>
    </contact>
  </location>
  <location_countries>
    <country>Indonesia</country>
  </location_countries>
  <reference>
    <citation>Giangiacomo A, Coleman AL. The Epidemiology of Glaucoma. In: Grehn F, Stamper R, editors. Glaucoma [Internet]. Berlin, Heidelberg: Springer Berlin Heidelberg; 2009 [cited 2016 Jun 14]. p. 13-21. Available from: http://link.springer.com/10.1007/978-3-540-69475-5_2</citation>
  </reference>
  <reference>
    <citation>Stamper R, Lieberman M, Drake M. Introduction and Classification of the Glaucomas. In: Becker-Shaffer's Diagnosis and Therapy of the Glaucomas. 8th ed. Mosby Elsevier; 2009. p. 1-7.</citation>
  </reference>
  <reference>
    <citation>Stamper R, Drake M, Lieberman M. Primary Open Angle Glaucoma. In: Becker-Shaffer's Diagnosis and Therapy of the Glaucomas. 8th ed. Mosby Elsevier; 2009. p. 239-57</citation>
  </reference>
  <reference>
    <citation>Sharaawy T, Sherwood M, Hitchings R. Glaucoma. 1st ed. Vol. 1. Philadelphia: Saunder Elsevier; 2009.</citation>
  </reference>
  <reference>
    <citation>Stamper RL, Lieberman MF, Drake MV. Laser Therapy. In: Becker-Shaffer's Diagnosis and Therapy of the Glaucomas. 8th ed. USA: Elsevier Health Sciences; 2009. p. 436-8.</citation>
  </reference>
  <reference>
    <citation>Stamper RL, Lieberman MF, Drake MV. Glaucoma outflow procedure. In: Becker-Shaffer's Diagnosis and Therapy of the Glaucomas. UK: Elsevier Health Sciences; 2009. p. 466-90.</citation>
  </reference>
  <reference>
    <citation>Eisenberg DL, Koo EY, Hafner G, Schuman JS. In vitro flow properties of glaucoma implant devices. Ophthalmic Surg Lasers. 1999 Sep-Oct;30(8):662-7.</citation>
    <PMID>10507569</PMID>
  </reference>
  <reference>
    <citation>Koura Y, Fukushima A, Nishino K, Ishida W, Nakakuki T, Sento M, Yamazoe K, Yamaguchi T, Misyoshi T, Ueno H. Inflammatory reaction following cataract surgery and implantation of acrylic intraocular lens in rabbits with endotoxin-induced uveitis. Eye (Lond). 2006 May;20(5):606-10.</citation>
    <PMID>15999134</PMID>
  </reference>
  <reference>
    <citation>Kim MS, Rhee SW. Effects on the surrounding tissues and morphological changes of components after implantation of PMMA and heparin surface modified PMMA intraocular lens in rabbit eyes. Korean J Ophthalmol. 1990 Dec;4(2):73-81.</citation>
    <PMID>2092164</PMID>
  </reference>
  <reference>
    <citation>Cioffi G. Basic and Clinical Science Course. 11th ed. American Academy of Ophtalmology; 2011. 211-215 p.</citation>
  </reference>
  <reference>
    <citation>Wilson MR, Mendis U, Smith SD, Paliwal A. Ahmed glaucoma valve implant vs trabeculectomy in the surgical treatment of glaucoma: a randomized clinical trial. Am J Ophthalmol. 2000 Sep;130(3):267-73.</citation>
    <PMID>11020403</PMID>
  </reference>
  <reference>
    <citation>Beck AD, Freedman S, Kammer J, Jin J. Aqueous shunt devices compared with trabeculectomy with Mitomycin-C for children in the first two years of life. Am J Ophthalmol. 2003 Dec;136(6):994-1000.</citation>
    <PMID>14644208</PMID>
  </reference>
  <reference>
    <citation>Jung KI, Lim SA, Park HY, Park CK. Visualization of blebs using anterior-segment optical coherence tomography after glaucoma drainage implant surgery. Ophthalmology. 2013 May;120(5):978-83. doi: 10.1016/j.ophtha.2012.10.015. Epub 2013 Jan 21.</citation>
    <PMID>23347982</PMID>
  </reference>
  <reference>
    <citation>Azuara-Blanco A, Katz LJ. Dysfunctional filtering blebs. Surv Ophthalmol. 1998 Sep-Oct;43(2):93-126. Review.</citation>
    <PMID>9763136</PMID>
  </reference>
  <reference>
    <citation>Clark A, Wax M, Civan M. Mechanisms of Glaucoma. In: Ophthalmology. 3rd ed. St. Louis, Mo: Mosby Elsevier; 2014. p. 1012-8.</citation>
  </reference>
  <reference>
    <citation>Chang DT, Jones JA, Meyerson H, Colton E, Kwon IK, Matsuda T, Anderson JM. Lymphocyte/macrophage interactions: biomaterial surface-dependent cytokine, chemokine, and matrix protein production. J Biomed Mater Res A. 2008 Dec 1;87(3):676-87. doi: 10.1002/jbm.a.31630.</citation>
    <PMID>18200554</PMID>
  </reference>
  <reference>
    <citation>Major MR, Wong VW, Nelson ER, Longaker MT, Gurtner GC. The foreign body response: at the interface of surgery and bioengineering. Plast Reconstr Surg. 2015 May;135(5):1489-98. doi: 10.1097/PRS.0000000000001193. Review.</citation>
    <PMID>25919260</PMID>
  </reference>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>August 6, 2019</study_first_submitted>
  <study_first_submitted_qc>August 8, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">August 9, 2019</study_first_posted>
  <last_update_submitted>August 8, 2019</last_update_submitted>
  <last_update_submitted_qc>August 8, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 12, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Indonesia University</investigator_affiliation>
    <investigator_full_name>Dr. dr. Virna Dwi Oktariana, SpM(K)</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Effectiveness</keyword>
  <keyword>Glaucoma Drainage Device</keyword>
  <keyword>Intraocular pressure</keyword>
  <keyword>Tissue Response</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glaucoma</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

